Cargando…

Molecular Heterogeneity in Glioblastoma: Potential Clinical Implications

Glioblastomas, (grade 4 astrocytomas), are aggressive primary brain tumors characterized by histopathological heterogeneity. High-resolution sequencing technologies have shown that these tumors also feature significant inter-tumoral molecular heterogeneity. Molecular subtyping of these tumors has re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parker, Nicole Renee, Khong, Peter, Parkinson, Jonathon Fergus, Howell, Viive Maarika, Wheeler, Helen Ruth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4347445/ https://www.ncbi.nlm.nih.gov/pubmed/25785247 http://dx.doi.org/10.3389/fonc.2015.00055

Ejemplares similares

Glioblastoma Recurrence Correlates With Increased APE1 and Polarization Toward an Immuno-Suppressive Microenvironment
por: Hudson, Amanda L., et al.
Publicado: (2018)

Intratumoral heterogeneity identified at the epigenetic, genetic and transcriptional level in glioblastoma
por: Parker, Nicole R., et al.
Publicado: (2016)

Editorial: Advances in Epithelial Ovarian Cancer: Model Systems, Microenvironmental Influences, Therapy, and Origins
por: Howell, Viive Maarika, et al.
Publicado: (2015)

Culture Models to Define Key Mediators of Cancer Matrix Remodeling
por: Fuller, Emily Suzanne, et al.
Publicado: (2014)

Glycolysis and Fatty Acid Oxidation Inhibition Improves Survival in Glioblastoma
por: McKelvey, Kelly J., et al.
Publicado: (2021)

The Extracellular Matrix in Epithelial Ovarian Cancer – A Piece of a Puzzle
por: Cho, Angela, et al.
Publicado: (2015)

Sub-acute Toxicity in Non-cancerous Tissue and Immune-Related Adverse Events of a Novel Combination Therapy for Cancer
por: McKelvey, Kelly J., et al.
Publicado: (2020)

Differential effects of radiation fractionation regimens on glioblastoma
por: McKelvey, Kelly J., et al.
Publicado: (2022)

PARP Inhibitors for Sensitization of Alkylation Chemotherapy in Glioblastoma: Impact of Blood-Brain Barrier and Molecular Heterogeneity
por: Gupta, Shiv K., et al.
Publicado: (2019)

Epithelioid glioblastoma exhibits a heterogeneous molecular feature: A targeted next-generation sequencing study
por: Pan, Rui, et al.
Publicado: (2022)

Visualising spatial heterogeneity in glioblastoma using imaging habitats
por: Waqar, Mueez, et al.
Publicado: (2022)

Tissues Harvested Using an Automated Surgical Approach Confirm Molecular Heterogeneity of Glioblastoma and Enhance Specimen's Translational Research Value
por: Zusman, Edie, et al.
Publicado: (2019)

Multi-Arm GlioblastoMa Australasia (MAGMA): protocol for a multiarm randomised clinical trial for people affected by glioblastoma
por: Kong, Benjamin Y, et al.
Publicado: (2022)

Heterogeneity of glioblastoma stem cells in the context of the immune microenvironment and geospatial organization
por: Silver, Aryeh, et al.
Publicado: (2022)

Clinical implications of microRNAs in human glioblastoma
por: Mizoguchi, Masahiro, et al.
Publicado: (2013)

Immunosuppression in Glioblastoma: Current Understanding and Therapeutic Implications
por: Himes, Benjamin T., et al.
Publicado: (2021)

Influence of Intratumor Heterogeneity on the Predictivity of MGMT Gene Promoter Methylation Status in Glioblastoma
por: Brigliadori, Giovanni, et al.
Publicado: (2020)

An Immune-Related Gene Pairs Signature Predicts Prognosis and Immune Heterogeneity in Glioblastoma
por: Zhang, Nijia, et al.
Publicado: (2021)

Exploring glioblastoma stem cell heterogeneity: Immune microenvironment modulation and therapeutic opportunities
por: Johnson, Amanda L., et al.
Publicado: (2022)

Current Challenges in Glioblastoma: Intratumour Heterogeneity, Residual Disease, and Models to Predict Disease Recurrence
por: Ellis, Hayley P., et al.
Publicado: (2015)

The Intratumoral Heterogeneity Reflects the Intertumoral Subtypes of Glioblastoma Multiforme: A Regional Immunohistochemistry Analysis
por: Bergmann, Natalie, et al.
Publicado: (2020)

Comprehensive Characterization of Alternative mRNA Splicing Events in Glioblastoma: Implications for Prognosis, Molecular Subtypes, and Immune Microenvironment Remodeling
por: Zhao, Liang, et al.
Publicado: (2021)

Intratumoral heterogeneity of endogenous tumor cell invasive behavior in human glioblastoma
por: Parker, Jonathon J., et al.
Publicado: (2018)

MRI radiomics and potential applications to glioblastoma
por: Hooper, Grayson W., et al.
Publicado: (2023)

Radiation-Induced Alterations in the Recurrent Glioblastoma Microenvironment: Therapeutic Implications
por: Gupta, Kshama, et al.
Publicado: (2018)

Molecular Heterogeneity in Pediatric Malignant Rhabdoid Tumors in Patients With Multi-Organ Involvement
por: Miller, Katherine E., et al.
Publicado: (2022)

Implications of Epithelial–Mesenchymal Plasticity for Heterogeneity in Colorectal Cancer
por: Pereira, Lloyd, et al.
Publicado: (2015)

Classification of Progression Patterns in Glioblastoma: Analysis of Predictive Factors and Clinical Implications
por: Jiang, Haihui, et al.
Publicado: (2020)

Cellular and Molecular Comparison of Glioblastoma Multiform Cell Lines
por: Demircan, Turan, et al.
Publicado: (2021)

Imaging-Genomics in Glioblastoma: Combining Molecular and Imaging Signatures
por: Liu, Dongming, et al.
Publicado: (2021)

Harnessing Pandemonium: The Clinical Implications of Tumor Heterogeneity in Ovarian Cancer
por: Blagden, Sarah P.
Publicado: (2015)

Heterogeneity of Soft Tissue Sarcomas and Its Implications in Targeted Therapy
por: Du, Xin-Hui, et al.
Publicado: (2020)

Photothermal Therapy for the Treatment of Glioblastoma: Potential and Preclinical Challenges
por: Bastiancich, Chiara, et al.
Publicado: (2021)

Autophagy-dependent ferroptosis as a potential treatment for glioblastoma
por: Xie, Yangchun, et al.
Publicado: (2023)

Molecular Characteristics in MRI-Classified Group 1 Glioblastoma Multiforme
por: Haskins, William E., et al.
Publicado: (2013)

Editorial: Molecular biology of biomarkers in diagnosis and treatment of glioblastoma multiforme
por: Zhao, Jianyi, et al.
Publicado: (2023)

Translational Potential of RNA Derived From Extracellular Vesicles in Multiple Myeloma
por: Reale, Antonia, et al.
Publicado: (2021)

Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma
por: DeCordova, Syreeta, et al.
Publicado: (2020)

Re-purposing Chloroquine for Glioblastoma: Potential Merits and Confounding Variables
por: Weyerhäuser, Patrick, et al.
Publicado: (2018)

Adoptive Cell Therapy: A Novel and Potential Immunotherapy for Glioblastoma
por: Wang, Jingyu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f09lbghhcqnnkt2u8232lootc9